Who invested in Immunic Therapeutics

One round we have observed, with the 6 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 9 months ago

Funding summaryUpdated 26 Oct 2026

$400Mraised across 1 round since 2026, from 1 source

Latest round: Round, $400MFeb 2026
Investors: 6

See who backed them

The rounds

Feb 2026
Round$400M
Source recorded

Founders and team

From Immunic Therapeutics's own website: 15 on the team.

Erik LundgrenChief Executive Officer, Director
Jason TardioPresident and
Chitrang DavéChief Data and Digital Officer
Dr. Michael A. PanzaraChief Medical Officer
Glenn WhaleyChief Financial Officer
Patrick WalshChief Business Officer
Werner GladdinesChief Development Officer
Dr. Jörg NeermannIndependent Director
Dr. Richard RudickIndependent Director
Elena RidloffIndependent Director
Inderpal SinghGeneral Counsel
Jon CongletonIndependent Director
Michael W. BonneyChair
Simona SkerjanecIndependent Director
Thor NagelDirector

Everyone who backed them

RA Capital ManagementPrivate equity1round

Janus Henderson InvestorsPrivate equity1round

Vivo CapitalPrivate equity1round

TCGPrivate equity1round

RTW Investments LLCGrowth equity1round

TCG CrossoverVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Immunic Therapeutics

Who invested in Immunic Therapeutics?

Immunic Therapeutics's investors include RA Capital Management, Janus Henderson Investors, Vivo Capital, TCG and RTW Investments LLC, and 1 more on record.

How much has Immunic Therapeutics raised?

Immunic Therapeutics has raised $400M across 1 round since 2026.

When did Immunic Therapeutics last raise?

Immunic Therapeutics's most recent round was an Undisclosed round of $400M in Feb 2026.

What was Immunic Therapeutics's biggest round?

Its most recent round, $400M in Feb 2026, is also its largest on record.

Who backed Immunic Therapeutics first?

Immunic Therapeutics's first round on record, in Feb 2026, was backed by RA Capital Management, Janus Henderson Investors and Vivo Capital and 3 others.